Skip to main content
Livermore
Livermore
ZHEN

Citadel Advisors LLC

SEC CIK
0001423053
Latest filing
Sep 1, 2026

TEVA holding history

Teva Pharmaceutical Industries Ltd in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TEVA overviewAll 13F holders of TEVAFull Q2 2026 holdings

Shares (Q2 2026)
73,304
Value
$2.48M
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of TEVA by Citadel Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202673,304$2.48M<0.1%+73,304NewHolders
Q1 20260$00.0%−3,847,855−100.0%Sold outHolders
Q4 20253,847,855$120.1M0.1%+2,613,700+211.8%AddedHolders
Q3 20251,234,155$24.9M<0.1%−978,931−44.2%ReducedHolders
Q2 20252,213,086$37.1M<0.1%−640,005−22.4%ReducedHolders
Q1 20252,853,091$43.9M<0.1%+467,669+19.6%AddedHolders
Q4 20242,385,422$52.6M<0.1%−1,083,040−31.2%ReducedHolders
Q3 20243,468,462$62.5M0.1%+1,700,049+96.1%AddedHolders
Q2 20241,768,413$28.7M<0.1%−3,341,713−65.4%ReducedHolders
Q1 20245,110,126$72.1M0.1%−6,493,437−56.0%ReducedHolders
Q4 202311,603,563$121.1M0.1%+8,573,014+282.9%AddedHolders
Q3 20233,030,549$30.9M<0.1%−1,455,496−32.4%ReducedHolders
Q2 20234,486,045$33.8M<0.1%−5,065,306−53.0%ReducedHolders
Q1 20239,551,351$84.5M0.1%+6,879,779+257.5%AddedHolders
Q4 20222,671,572$24.4M<0.1%+144,815+5.7%AddedHolders
Q3 20222,526,757$20.4M<0.1%−7,119,914−73.8%ReducedHolders
Q2 20229,646,671$72.5M0.1%+7,778,203+416.3%AddedHolders
Q1 20221,868,468$17.5M<0.1%−505,182−21.3%ReducedHolders
Q4 20212,373,650$19.0M<0.1%−574,697−19.5%ReducedHolders
Q3 20212,948,347$28.7M<0.1%−89,390−2.9%ReducedHolders
Q2 20213,037,737$30.1M<0.1%+1,084,671+55.5%AddedHolders
Q1 20211,953,066$22.5M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.